SCHEMBL20867172

SCHEMBL20867172

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)OC(=N)c1ccccc1N1CCCOCC1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 17/20 0.56
▸ CCKAR P32238 3/20 0.50
▸ CCKBR P32239 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866674 0.97 CBLB (0.59) CBLBCCKARCCKBR
SCHEMBL24611909 0.97 CBLB (0.59) CBLBCCKARCCKBR
SCHEMBL24611936 0.93 CCKBR (0.53) CBLBCCKARCCKBR
SCHEMBL20867137 0.89 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL24611988 0.89 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL20866755 0.88 CBLB (0.59) CBLBCCKARCCKBR
SCHEMBL20866622 0.88 CBLB (0.61) CBLBCCKARCCKBR
SCHEMBL24611933 0.88 CBLB (0.53) CBLBCCKARCCKBR
SCHEMBL20867277 0.88 CBLB (0.53) CBLBCCKARCCKBR
SCHEMBL20867037 0.88 CBLB (0.54) CBLBCCKARCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback